Six 20 minutes webcasts, one to watch each month.
ACR POINT-OF-CARE TESTING: A GAME CHANGER FOR DETECTING AND MANAGING KIDNEY DISEASE
Watch the episodes
ACR – The window to early kidney disease
¿No puede asistir a la transmisión en directo? No se preocupe. Regístrese de todos modos y podrá verlo cuando desee.
Watch the episodes
Should you screen for kidney damage?
What do the guidelines say?
Impact of ACR POC testing on the diagnosis and management of diabetic kidney disease
Case study 1 - more details coming soon
Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1. Early detection can slow disease progression or even prevent it altogether2 — which is why testing in at-risk groups is so important.
Join this livestream series of 20 minutes each to learn how early detection can slow disease progression or even prevent it altogether.
Our international speakers will discuss the role of rapid diagnostics in disease prevention, with point-of-care testing such as an Albumin Creatinine Ratio (ACR) assay, enabling healthcare providers to detect, and treat, kidney disease in minutes.
Learn more about current guidelines and kidney disease prevention and management.
Series of six livestream events covering:
- Importance of regular testing for early detection and monitoring in high-risk patients
- Importance of ACR testing beside the determination of eGFR
- Latest guidance on disease prevention and management
- Case studies
Sundström J, Bodegard J, Bollmann A et al. CaReMe CKD study: Prevalence, outcomes, and cost of CKD in a contemporary population of 2.4 million patients from 11 countries. The Lancet Regional Health – Europe 2022;00: 100438
The International Society of Nephrology (ISN). Chronic Kidney Disease: HYPERLINK https://www.worldkidneyday.org/facts/chronic-kidney-disease
PROF. TROND JENSSEN
Professor of Nephrology in the Department of Clinical Medicine, University of Oslo, and leader of the Research Group for Transplantation Medicine, Section of Nephrology, Rikshospitalet, Oslo University Hospital
PROF. PETER ROSSING
Head of department for Complications Research at Steno Diabetes Center Copenhagen, and Professor in Endocrinology at Department of Clinical Medicine, University of Copenhagen
PROF. GOTTFRIED RUDOFSKY
Specialist in Internal Medicine – Endocrinology and Diabetology, Nephrology. Head of private practice in the fields of internal medicine and endocrinology, Olten, Switzerland
Los puntos de vista y opiniones presentados son solo de los autores. El contenido de este webcast está destinado únicamente a fines informativos/educativos.
MORE SPEAKERS TO BE ANNOUNCED SOON.
© 2023 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model. Products available in select markets only. COL-16422 01/2023